ID

32334

Description

This ODM file contains a form for the documention required at the pre-dose visits. Study ID: 103880 Clinical Study ID: ARI103880 Study Title: An open label, single dose, randomized, three period crossover study to investigate the relative bioavailability of 0.5 mg of dutasteride from soft gelatin capsules (reference) vs. soft gelatin capsules containing two investigational formulations in healthy male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor; Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Prostatic Hyperplasia

Mots-clés

Versions (2)

1. 26/10/2018 26/10/2018 -
2. 29/10/2018 29/10/2018 -

Détendeur de droits

GlaxoSmithKline

Téléchargé le

26 octobre 2018

DOI

Pour une demande vous connecter.

Licence